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A B S T R A C T
Purpose: The National Health Service in the United Kingdom compares favourably on many international
measures of quality and cost-effectiveness. It has many centres of excellence for epilepsy care and in
some areas is a world-leader. However, for over twenty years there have been concerns that the
provision of good quality care is variable and in many areas major improvements are required. We report
the results of the latest major survey into the quality of epilepsy care in the NHS.
Methods: Four target groups were sent questionnaires: acute hospital trusts, Clinical Commissioning
Groups, local authorities and patients. Each questionnaire was speciﬁcally designed by Epilepsy Action
after reviewing national guidance and quality standards.
Results: We present the key results of the survey and we discuss them in the context of the latest
national guidelines, quality standards, the organisational structure of the NHS and the research
literature.
Conclusion: Although there are some examples of excellent services for people with epilepsy these
results show that overall there has been little improvement in recent years and there continues to be
signiﬁcant geographical variability in quality with many areas offering sub-optimal care.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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1.1. Epilepsy services in the United Kingdom National Health Service
The National Health Service in the United Kingdom compares
favourably on many international measures of quality and cost-
effectiveness [1]. Despite frequent and ongoing reforms, the
United Kingdoms’ National Health Service (NHS) is intended to
be a comprehensive service, available to all, in which access is
based clinical need and not an individual’s ability to pay. The
NHS ‘‘aspires to the highest standards of excellence and§ One of the authors of this paper is a member of the current editorial team of
Seizure. The supervision of the independent peer review process was undertaken
and the decision about the publication of this manuscript were made by other
members of the editorial team.
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1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reprofessionalism’’ and to ‘‘put(ting) patients at the heart of
everything it does’’ [2].
Just over 20 years ago, the Clinical Standards Advisory Group, an
expert group established to advise United Kingdom (UK) health
ministers, published their report into epilepsy and highlighted
infrequent routine monitoring, a lack of coordination and poor
communication between primary and secondary care. They
emphasised that General Practitioners (GPs) need help and support
with the clinical management of more complex aspects of epilepsy
care [3]. The Epilepsy Needs Documents were published in 1993
[4] and 1998 [5], and since then, many published reports by
governmental and non-governmental organisations and research
studies have compared the clinical and social reality with the
aspirations expressed in these ofﬁcial documents and suggested
how services for people with epilepsy could be developed to match
them better.
In 2002 the National Sentinel Audit of Epilepsy-Related Deaths
[6] highlighted the mortality associated with uncontrolled
epilepsy and that systemic inadequacies in the delivery of care
meant that many of these deaths were potentially preventable. In
response to this report, the Department of Health (DoH) publishedserved.
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which made speciﬁc recommendations including the decision to
focus the National Service Framework (NSF) for long-term
conditions on neurological conditions [9]. The DoH also provided
additional funding of £1.2 million (s1.52/$1.93 million) [10]. The
NSF consists of eleven quality requirements (QRs). QR2 for
example, refers to ‘‘early recognition, prompt diagnosis and
treatment’’. This QR stipulates that ‘‘people suspected of having
a neurological condition are to have prompt access to specialist
neurological expertise for an accurate diagnosis and treatment as
close to home as possible’’. The eleven QRs are due to be fully
implemented in 2015 via Clinical Neuroscience Networks led by
Primary Care Trusts (PCTs) and Strategic Health Authorities (SHAs).
In the same year as the DoH’s action plan (2002), the Scottish
Intercollegiate Guidelines Network (SIGN) published their ﬁrst
clinical guideline on Diagnosis and Management of Epilepsy in
Adults [11], followed in 2004 by the guideline of the National
Institute for Clinical Excellence [12]. Both sets of guidelines were
intended to provide evidence-based advice on the optimal
treatment of epilepsy in NHS settings. Epilepsy also became part
of the Quality Outcomes Framework for GPs, a system under which
GP practices receive additional income for speciﬁed activities (such
as carrying out annual reviews of patients with epilepsy) [13]. In
2005, the Action on Neurology Programme [14], which arose as a
response to the challenge of delivering the NSF’s QRs, illustrated
some national examples of best practice. A proposal to develop a
competency framework for GPs and other health care professionals
with a special interest in epilepsy was published in 2007 [15]. In the
same year the All Party Parliamentary Group on Epilepsy published
The Human and Economic Cost of Epilepsy [16]. In 2009 Epilepsy
Action published Time for Change [17] and in 2011 the Royal College
of Physicians and the Association of British Neurologists published
Local Adult Neurology Services for the Next Decade – all making
speciﬁc recommendations, many already included in previous
reports. The latest major reports into epilepsy care in the NHS are the
National Audits of Seizure Management in Hospitals (NASH) [18,19]
which highlighted highly variable care in emergency departments
(EDs) when patients present with seizures.
1.2. Current organisation of the NHS in England
The NHS in the UK is organised differently in each of the
constituent nations (England, Scotland, Wales and Northern
Ireland). In England it is run by NHS England which is an
independent organisation funded from tax revenue by the
Department of Health in England. Its remit is to improve health
outcomes and deliver high-quality care for people in England. This
is achieved by direct commissioning of specialised services such as
neurology and by funding and overseeing Clinical Commissioning
Groups (CCGs) which are clinically-led organisations which
commission services for local populations. There are 211 CCGs
in England with a mean population of 251,693 (range 61,607–
863,433) [20] and an average size of 618 km2 per CCG [21]. CCGs
replaced Primary Care Trusts (PCTs) which were previously
responsible for commissioning local services, in April 2013.
In England, in-patient and most specialist outpatient services
(including almost all outpatient epilepsy services) are currently
provided by 160 acute hospital trusts. Emergency hospital care
relating to epilepsy is commissioned by local CCGs, specialist care
(which currently includes neurological outpatient care) is commis-
sioned centrally by NHS England. Acute trusts differ considerably in
size, and although they mainly serve their local population, they do
not have geographical boundaries and are required to treat patients
from any area. The Ofﬁce for National Statistics mid-2013
population estimate for England was 53,865,800, therefore each
of England’s 160 acute trusts serves a nominal 336,661 people.Local government in England also has responsibility for health.
Local authorities are required to host Health and Well Being Boards
(HWBBs) which must produce a Joint Strategic Needs Assessment
(JSNAs) to inform the strategy of the local authority and the local
CCG. HWBBs consist of representatives of the authority, the CCG,
social services, children’s services, public health, patients and other
invited members. Their remit is to plan the best way to meet the
needs of their local population and reduce inequalities in health.
1.3. A Critical Time
In January 2013 Epilepsy Action published their report entitled
A Critical Time for Epilepsy in England. It was a survey of patients
and organisations responsible for epilepsy service provision in
England (the other devolved nations of the UK were not included).
It was based on the responses of four target groups: acute hospital
trusts, CCGs/PCTs, local authorities and patients. This paper is
intended to present the key results of this snapshot of epilepsy care
and to disseminate the ﬁndings of the survey to a wider audience
national and internationally. We discuss the context of the results
and draw conclusions about the quality of current epilepsy service
provision in England.
2. Methods
Four separate questionnaires were designed for each of the
target groups by Epilepsy Action, the largest membership-lead
epilepsy organisation in the UK. The surveys were lead by their
Policy and Campaigns team. Initial drafts were drawn-up after
review of up-to-date national guidance including NICE Clinical
Guidance, the National Service Framework for long-term condi-
tions and in anticipation of the NICE quality standards which
were at that time due to be published imminently. The Medical
Advisory Board of Epilepsy Action reviewed and provided
feedback on all four questionnaires. In addition to this, the
patient survey was reviewed and user tested by six people
with epilepsy. This process took place between February and
May 2012.
2.1. Target groups
2.1.1. Acute hospital trusts
A list of the relevant acute hospital trusts in England was
compiled from the NHS Choices website (specialised trusts that
were known not to provide epilepsy care or treatments were not
contacted). The initial requests were entered under Freedom of
Information requests by email to Information Governance teams,
on 4 May 2012. The trusts were given the option of supplying the
data online or by email or by post. Two reminders were sent. A total
of 152 trusts were contacted. 10/152 (6.6%) responded stating that
they did not provide epilepsy services and 62/152 (40.1%) did not
respond (or responded after the deadline). A total of 80/152 (53%)
trusts responded with completed questionnaires.
2.2. Primary Care Trusts and Clinical Commissioning Groups
CCGs were set up by the Health and Social Care Act 2012. They
began operating in shadow form in 2012 before taking on their full
legal responsibilities in April 2013. The survey was therefore
conducted during the transition period over which responsibility
transferred from PCTs to CCGs. A list of the 208 CCGs was
purchased from Specialist Info, a company who specialise in
maintaining databases of doctors and health care providers. A
total of 158/208 (75.9%) of the CCGs contacted responded to the
survey.
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A list of local authorities was compiled by Epilepsy Action from
www.gov.uk, totalling 149. The initial request was also entered
under Freedom of Information requests by email to Information
Governance teams in May 2012. Again, data could be supplied via
an online form or returned by email or post. Two reminders were
sent. 113/149 (75.8%) local authorities responded.
2.4. Patients
The patient questionnaire was available through a link on the
Epilepsy Action website (www.epilepsy.org.uk). All stakeholders of
the charity were invited to complete a questionnaire. An email
promoting the survey was sent to 3,876 members of the
organisation, based in England, for whom the charity had an
email address a although non-members were not speciﬁcally
contacted, they were welcome to take part. The survey was
promoted via Twitter (5311 followers at the time) and Facebook
(17,450 members at the time). The questionnaire was live from 31
May 2012 to 7 August 2012. 1086 responses were received.
3. Results
3.1. Acute hospital trusts
3.1.1. In-patient and out-patient services
The large majority of trusts provided diagnostic services (73/80,
91.3%) and/or outpatient treatment (79/80, 98.8%) but only 15%
(12/80) offered surgical treatment. The vast majority of trusts (76/
79, 96.2%) had referred to tertiary centres at some point for
diagnosis, treatment or ongoing care. Table 1 shows the availability
of out-patient clinics for patients with epilepsy.
The majority of adult in-patient management of epilepsy
problems is done by neurologists (31/66, 47.0%), or general
physicians with input from neurologists or epilepsy specialist
nurses (25/66, 42%). However, 15% (10/66) of respondents stated
in-patient management was purely from general physicians. For
children, the majority of in-patient management comes from
general paediatricians (52/68, 76%) with only 4% (3/68) of
respondents describing management by paediatric neurologists.
General paediatricians with input from paediatric neurologists or
epilepsy specialist nurses managed the remaining 19% (13/68).
Table 2 shows the mean number of epilepsy specialists that are
employed within acute trusts.
3.2. Waiting times
The mean of reported ‘‘average’’ waiting times for adults with
suspected epilepsy to see an epilepsy specialist for an initial
assessment was 37 days (range 3–84). Recognising ﬂuctuations in
waiting times, respondents were encouraged to report minimum
and maximum waiting times for initial appointments. The mean of
reported maximum waiting times was 60 days (range 13–154Table 1
Availability of epilepsy clinics. Percentage of trusts offering clinics at designated interv
Every week Every 2
weeks
Ev
m
General neurology clinics 96.3% 
General epilepsy clinics 65.0% 6.3% 2
First seizure clinics 36.3% 7.5% 8
Paediatric transition clinics to adult care 1.3% 7.6% 16
Adult transition clinics to geriatrics 2
Pre-surgical clinics 7.5% 5
Pre-conception clinics 16.5% 1.3% 8days). The waiting time data for adults to see non-epilepsy
specialists was very similar as were the equivalent data for
children. The median number of epilepsy nurse specialists in each
trust was 1 (range 0–8) for adults, 0 (range 0–9) for children and 1
(range 0–8) for people with learning disabilities.
3.3. Access to investigations
Table 3 shows the percentage of acute hospitals with access to
speciﬁc investigations and the mean of the reported average
waiting time for these tests.
3.4. Care planning
Care plans were offered routinely to patients with epilepsy in
48.8% (39/80) of trusts.
3.5. Emergency care
98.8% (79/80) of trusts operate an Emergency Department (ED).
72.7% (56/77) of trusts have a protocol for someone presenting to
the ED after a suspected ﬁrst seizure, 66.2% (51/77) can refer
directly to a ﬁrst seizure clinic from ED and 57.1% (44/77) have a
protocol for the management of seizures in patients with epilepsy.
The mean number of ED attendances with seizures, or
suspected seizures, reported by responding trusts per year in
adults was 653. These represented a mean of 17% of ED
attendances for ambulatory care sensitive conditions (ACSCs)
[22]. ACSCs are deﬁned as clinical conditions for which the risk of
emergency hospital admission can be reduced by timely and
effective ambulatory care (primary care, community services and
outpatient care) [23]. An average of 43% attending ED with seizures
were admitted, 12% were referred to ﬁrst seizure clinics and 24%
were referred back to primary care.
The mean reported number of epilepsy-related attendances per
year in children was 205. Such admissions represented 18% of ED
attendances for ambulatory care sensitive conditions. An average
of 49% of these ED attendances led to admissions, 16% were
referred to ﬁrst seizure clinics and 21% were referred back to
primary care.
3.6. Clinical Commissioning Groups and Primary Care Trusts
Most CCGs were working independently to commission
services for their patients but a signiﬁcant minority (27.2%) (43/
158) were working in confederations. 20.9% (33/158) had
appointed a clinical lead for neurology, and 17.1% (27/158) for
epilepsy. The clinicians to whom a GP can refer patients with
epilepsy (expressed as percentages of all CCGs) were as follows:
epilepsy specialist consultant 55.7%, general adult neurologist
78.5%, GP with a special interest in epilepsy 10.1%, paediatric
neurologist 48.7% and general paediatrician 62.0%. Table 4
summarises the services that CCGs declared that they intended
to offer to people with epilepsy.als. NA: not available.
ery
onth
Every 3
months
Every 6
months
Between
1–2/year
<1/year NA
1.3% 2.5%
.5% 26.3%
.8% 1.3% 46.3%
.5% 5.1% 2.5% 2.5% 64.6%
.5% 1.3% 96.3%
.0% 1.3% 1.3% 85%
.9% 1.3% 72.2%
Table 4
Percentage of CCGs offering speciﬁc epilepsy services.
Yes No Don’t know
An outpatient clinic service 56.3% 11.4% 32.3%
Epilepsy specialist nurse 46.2% 18.4% 35.4%
A diagnostic pathway 46.2% 15.2% 38.6%
An A&E attendance protocol 31.6% 15.8% 52.5%
A care planning service 31.6% 22.8% 45.6%
A ﬁrst seizure clinic 30.4% 19.6% 50.0%
Support groups for people with
epilepsy
28.5% 24.7% 46.8%
An epilepsy information service 27.8% 25.9% 46.2%
A surgical pathway 23.4% 24.7% 51.9%
A transition service 20.9% 22.2% 57.0%
A shared electronic care plan 13.3% 32.3% 54.4%
An epilepsy expert patient
programme
12.0% 29.7% 58.2%
A GPwSIa epilepsy led service 8.9% 52.5% 38.6%
A telemedicine service 5.7% 34.8% 59.5%
a GP with a special interest in epilepsy.
1 per week,
280, (26%)
Seizure Free,
313, (29%)
Table 2
The mean number of healthcare professionals that are employed within acute trusts
listed in descending order.
Median (range)
Paediatricians 9 (0–32)
Geriatricians 5 (0–23)
Neurologists 3 (0–25)
Adult epilepsy specialistsa 1 (0–10)
Epilepsy nurse specialists (adults) 1 (0–8)
Epilepsy nurse specialists (adults with LDs) 1 (0–8)
Paediatric epilepsy specialists 1 (0–7)
Neurosurgeons 0 (0–16)
Neuropsychologists 0 (0–9)
Epilepsy nurse specialists (children) 0 (0–9)
Paediatric neurologists 0 (0–6)
Neuropsychiatrists 0 (0–5)
a Adult epilepsy specialist is a consultant with expertise in epilepsy as
demonstrated by training and continuing education in epilepsy, peer review and
regular audit of diagnosis. Epilepsy must be a signiﬁcant part of their clinical
workload (equivalent to at least one half-day a week).
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99/113 (87.6%) of the authorities that responded had a JSNA for
2012–13. The JSNA is the key document which informs the strategy
of the local authority and the local CCG. Of these, only 74.7% (74/
99) had a section on long-term conditions. Only 29.3% (29/99) had
a section on neurology and only 27.3% (27/99) had a section on
epilepsy. Of those with a JSNA 84.8% (84/99) consulted with
patients. The most common methods of consulting were existing
structures such Healthwatch (66/84, 78.6%), surveys (40/84, 47.6%)
and public meetings (35/84, 41.7%).
4. Patients
4.1. Demographics
1086 patients (or their carers) completed the online question-
naire. 35.8% were male and 63.9% were female. 9.2% were under 12
years old, 7.1% were 13–18, 78.2% were 19–65 and 4.5% were
over 65.
4.2. Seizure control
Only 28.8% (313/1086) were seizure free. Fig. 1 shows the
frequency of seizures amongst the other 773 patients who were not
seizure free. Those who were not seizure free were asked how long
have your seizures been uncontrolled. 21.5% (166/773) had been
uncontrolled for less than a year, 13.7% (106/773) for 1–2 years, 48%
(372/773) for 2–10 years and 16.7% (129/773) for over 20 years.
4.2.1. Anti-Epileptic Drugs (AEDs)
94.8% (1029/1086) were taking AEDs. The majority (80.7%)
(830/1029) were taking 1–2 AEDs but the remaining 19.4% (199/
1029) patients were taking more, some more than ﬁve.Table 3
Percentage of acute hospitals with access to speciﬁc investigations, either within
the trust or elsewhere, and the mean of the reported average waiting time for these
tests in days.
Yes Yes –
elsewhere
No Waiting time
(range)
EEG 71.3% 27.5% 1.3% 29 (0–200)
Ambulatory EEG 48.8% 46.3% 5.0% 39 (0–200)
MRI 100% 0.0% 0.0% 28 (0–84)
CT 98.8% 1.3% 0.0% 22 (0–64)
Video telemetry 23.8% 67.5% 8.8% 64 (0–200)4.2.2. Waiting times for investigations
Of those patients that had had an MRI scan in the last two years,
47.4% (239/504) waited longer than four weeks and some patients
waited for longer than eight months. Of those patients that had had
an EEG within the last two years, 43.5% (253/581) had waited
longer than four weeks and, as with MRI, some patients waited
longer than eight months.
4.3. Ongoing care
The main health care professional reported as looking after
patients’ seizure disorder varied but the majority either stated that
they were under the care of an epilepsy specialist consultant
(27.3%) (296/1083), a GP (24.0%) (260/1083) or a general
neurologist (22.0%) (238/1083). 66% (676/1030) had received an
invitation for an annual review. Annual reviews were most
frequently carried out by adult/paediatric epilepsy specialist
consultants (34.1%) (244/657), general neurology consultants
(20.2%) (133/657), GPs (19.9%) (131/657) or epilepsy specialist1 per month,
241, (22%)
1 per 6
months,
144, (13%)
1 per year,
108, (10%)
Fig. 1. Seizure frequency amongst the 773/1086 who were not seizure free.
J.M. Dickson et al. / Seizure 30 (2015) 26–3130nurses (12.9%) (85/657). The review resulted in no changes in
50.0% (326/652), treatment changes in 41.6% (271/652), referral to
a consultant 7.4% (48/652) and referral to an epilepsy specialist
nurse in 2.1% (14/652). Only 51.8% (561/1082) had ever been
referred to an epilepsy specialist nurse and only 13.7% (149/1084)
had a written care plan.
Only 13% (141/1086) of patients could remember a healthcare
professional discussing bone health with them. Less than 50% of
patients recalled ever being provided with information about key
medical, social and psychological aspects of living with epilepsy
such as family planning and contraception, epilepsy related death
and driving. Nevertheless, the majority of patients felt they were
well informed about their epilepsy (63.8%) (693/1086) and the
majority trusted their doctor to make choices about their epilepsy
treatment (55.4%) (602/1086).
Discussion
4.4. Summary
This paper presents the results of four recent complementary
surveys of epilepsy services in the NHS in England. It shows a
mixed picture but overall there has been little improvement since
2009, when Time for Change [17] was published. Some commis-
sioners, providers and local authorities have adopted best practice
standards and provide proactive and high quality services for
people with epilepsy. However, there is signiﬁcant variability and
many CCGs offer suboptimal care which does not meet NICE’s
Quality Standards [24,25].
Overall, commissioning of epilepsy services seems to have a
very low priority despite the relatively high prevalence of epilepsy.
Estimates vary but approximately 1% of the UK population have
epilepsy [26]. Epilepsy is an ambulatory care sensitive condition.
With optimum antiepileptic drug therapy (AED) 70% of people will
become seizure free [27] but actual seizure freedom rates in the UK
are likely to be much lower at around 50%. Recurrent seizures
cause morbidity, mortality and increase health costs. Unscheduled
care (hospital treatment and admission) accounts for the majority
of costs associated with uncontrolled epilepsy [28]. Despite this
many patients receiving treatment for epilepsy have never
received advice from an epilepsy specialist which leads to mis-
diagnosis, sub-optimal treatment and inadequate provision of
advice [29].
Epilepsy does not feature in most JSNAs, the key document
which informs the strategy of the local authority and the local CCG,
and many key features of a high quality epilepsy service, such as ED
protocols, are not commissioned by CCGs. Many CCGs have no
appointed lead for neurology. There remain long waiting times for
out-patient clinics (including ﬁrst ﬁt clinics) for the management
of epilepsy. These clinics are often not run by epilepsy specialists
(general neurologists and general physicians) who often do not
have access to epilepsy specialist nurses especially in paediatric
services. Although the evidence-base could be stronger, epilepsy
specialists nurses are considered a key part of the epilepsy team in
many centres where they have diverse roles and have been shown
to improve the quality of care for people with epilepsy [30]. There
are long waiting times for investigations such as MRI and EEG, care
plans are rarely put in place, dedicated transition clinics are
available only in a small minority of CCGs.
4.5. Limitations of the study
Much of the information required to assess the quality of
epilepsy services in England is not in the public domain and the
questionnaires did not capture all the key metrics of good quality
epilepsy care. It was important to balance collecting as much goodquality data as possible with the time requirement for completing
the questionnaire. Too many questions were likely to adversely
affect the response rate from organisations and so the ﬁnal
questionnaires were a pragmatic balance of these two priorities.
Data collection for A Critical Time required the use of signiﬁcant
resources by Epilepsy Action, a major UK charity, through freedom
of information requests. The quality of the data was dependent on
diligent and accurate recording by organisations and in some areas
this was lacking and data quality was poor. Many organisations
(trusts, CCGs and local authorities) were slow in making returns,
which resulted in follow-up requests from EA, but despite this
some did not submit a return at all. Some organisations submitted
returns which contained gaps in the data i.e. no entry for one or
more of the variables. The denominator is included for each
percentage cited in this paper so that readers can see how
frequently this occurred for each variable. Finally, making
comparisons between hospital trusts is difﬁcult. Acute hospital
trusts are required to treat all patients that present or are referred
to them and as such do not have populations which would be the
obvious denominator when, for example, comparing stafﬁng
levels. Other denominators are either unsatisfactory or not in
the public domain.
All data was manually inspected by JMD and returns that were
deemed to be inaccurate, non-representative or misleading were
excluded. This process of exclusions was separate to the analysis
undertaken by EA and so ﬁgures in this paper and the ofﬁcial 2013
report may vary slightly. In the interests of brevity, analysis of
some variables from the original questionnaires are not included in
this paper; the main reasons for not including variables were that
the variable was deemed of less interest or that the data quality
was poor. Full-length versions of the questionnaires are available
as additional on-line content.
The respondents contributing to the patient survey described
here are unlikely to be fully representative of individuals with
epilepsy living in England, indeed given the self-reporting of
epilepsy, it is possible some may not truly have epilepsy. The
proportions of patients reporting uncontrolled seizures and the
proportion of patients stating that they received their epilepsy
health care in specialist settings was higher than expected [31].
However, the fact that most respondents to this survey were being
treated by epilepsy experts and that most had uncontrolled
seizures means that the low number of patients who reported
having a care plan is particularly disconcerting (given that the
provision of a care plan, agreed between health care professional
and patient) has been clearly recommended as a feature of good
epilepsy care since the publication of the NICE guidelines in 2004.
Regardless of sampling bias, the result of the patient question-
naires (especially when considered together with the other
ﬁndings of this study) are consistent with an overall impression
that a large proportion of England’s estimated 495,000 [32] people
with epilepsy are not being optimally treated [33]. Finally, the
report did not include questions about the provision of services for
people with non-epileptic attack disorder (NEAD) which was
beyond the scope of this report, but who nevertheless make-up a
signiﬁcant proportion of patients seen in epilepsy clinics and for
whom service provision is equally variable [34].
5. Conclusions
Despite its’ limitations this report contains the most up-to-date
data available on epilepsy services in England and we hope it is
helpful for people trying to improve these services. The recent
reorganisation of the NHS has created huge challenges but the
recent ﬁve-year plan from NHS England has created a unique
opportunity for the NHS to respond to the needs of people with
epilepsy. It emphasises empowering patients, new models of care
J.M. Dickson et al. / Seizure 30 (2015) 26–31 31including multi-speciality community providers, more integration
of acute and emergency care, diverse solutions and local
leadership. Epilepsy Action made a series of recommendations
in A Critical Time for improving epilepsy care in England many of
which would be in keeping with the aspirations of the new NHS.
Time will tell whether the NHS can respond to the challenges
highlighted in this report.
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